Current Status of Bill HR 1375
Bill HR 1375 is currently in the status of Bill Introduced since March 3, 2023. Bill HR 1375 was introduced during Congress 118 and was introduced to the House on March 3, 2023. Bill HR 1375's most recent activity was Referred to the Subcommittee on Health. as of March 10, 2023
Bipartisan Support of Bill HR 1375
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0
Policy Area and Potential Impact of Bill HR 1375
Primary Policy Focus
Health
Alternate Title(s) of Bill HR 1375
EFFECTIVE ActEFFECTIVE ActEnsuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement ActTo allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.